BRCA1 Antikörper (AA 1151-1200)
Kurzübersicht für BRCA1 Antikörper (AA 1151-1200) (ABIN6742370)
Target
Alle BRCA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1151-1200
-
Spezifität
- Human BRCA1
-
Homologie
- Percent identity by BLAST analysis: Human (100%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa1151-1200 of human BRCA1 (P38398, NP_009225). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Monkey, Marmoset (100%), Opossum (80%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.
Not recommended for: IHC-P -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- BRCA1 (Breast Cancer 1 (BRCA1))
-
Andere Bezeichnung
- BRCA1
-
Hintergrund
-
Name/Gene ID: BRCA1
Synonyms: BRCA1, BROVCA1, BRCC1, Breast cancer 1, early onset, PPP1R53, PSCP, PNCA4, RING finger protein 53, RNF53, BRCAI, Breast cancer 1 early onset, IRIS -
Gen-ID
- 672
-
NCBI Accession
- NP_009225
-
UniProt
- P38398
-
Pathways
- Zellzyklus, DNA Reparatur, Intracellular Steroid Hormone Receptor Signaling Pathway, Positive Regulation of Response to DNA Damage Stimulus
Target
-